Interval cancers and cancers in non-attenders in the ostergotland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1453-1460

  Vitak, B ^a   Stal O ^a   Manson J C ^a   Thomas, B A ^b   Arnesson, L G ^a   Ekelund, L ^a   Mare K ^a   Nordenskjold B ^a   Kallstrom A C ^c   Bang H ^d  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Jarvis Breast Screening Centre   (United Kingdom)

^c VRINNEVI HOSPITAL   (Sweden)

^d Motala General Hospital   (Sweden)

Author keywords

Distant recurrence; Interval breast cancer; Metastatic potential; S phase fraction; Screening

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CELL CYCLE S PHASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; S PHASE; SWEDEN; TIME FACTORS;

EID: 0343812058     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00185-8     Document Type: Article

References (22)

1. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am 1992, 30, 187-210.
2. Anderson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988, 297, 943-948.
3. Shapiro S, Venet W, Strax P, Venet L. Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of Greater New York study. In Day NE, Miller AB, eds. Screening for Breast Cancer. Toronto, H Huber Publishers, 1988.
4. Moss SM, Ellman R, Coleman D, Chamberlain J. Survival of patients with breat cancer diagnosed in the United Kingdom trial of early detection of breast cancer. J Med Screening 1994, 1, 193-198.
5. Frisell J, Eklund G, Hellström L, Lidbrink E, Rutquist LE, Somell A. Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Treat Res 1991, 18, 49-56.
6. Hakama M, Holli K, Isola J, et al. Aggressiveness of screen-detected breast cancers. Lancet 1995, 345, 221-224.
7. Kallioniemi OP, Kärkeinen A, Auvinen O, Matilla J, Koivula T, Hakama M. DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential. Int J Cancer 1988, 42, 697-702.
8. Heuser LS, Spratt S, Kuhns JG, Chang AFC, Polk HC, Buchanan JB. The association of pathologic and mammographic characteristics of primary human breast cancers with 'slow' and 'fast' growth rates and with axillary lymph node metastases. Cancer 1984, 53, 96-98.
9. DeGroote R, Rush BF, Milazzo J, Warden MJ, Rocko JM. Interval breast cancer: a more aggressive subset of breast neoplasias. Surgery 1983, 94, 543-547.
10. Ikeda BM, Andersson I, Wattsgård C, Janzon L, Linell F. Interval carcinomas in the Malmö mammographic screening trial: radiographic appearance and prognostic considerations. AJR 1992, 159, 287-294.
11. Frisell J, von Rosen A, Wiege M, Nilsson B, Goldman S. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Treat Res 1992, 24, 11-16.
12. Holmberg L, Tabar L, Adami HO, Bergström R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986, ii, 27-30.
13. Duffy SW, Tabar L, Fagerberg G, et al. Breast screening, prognostic factors and survival-results from the Swedish two country study. Br J Cancer 1991, 64, 1133-1138.
14. Holmberg L, Ponten J, Adami HO. The biology and natural history of breast cancer from the screening perspective. World J Surg 1989, 13, 25-30.
15. Burrell HC, Sibbering DM, Wilson AR, et al. Screening interval cancers: mammographic features and prognostic factors. Radiology 1996, 199, 811-817.
16. von Rosen A, Frisell, Nilsson, Wiege M, Auer G. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm mammography screening project. Acta Oncol 1992, 31, 399-402.
17. Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ. Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 1995, 31, 1830-1835.
18. Lidbrink E, Frisell J, Brandberg Y, Rosendahl I, Rutquist LE. Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance. Breast Cancer Treat Res 1995, 35, 267-275.
19. Haybittle JL, Blarney RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer 1982, 45, 361-366.
20. Meyer JS, Wittliff JL. Regional heterogeneity in breast carcinoma: thymidine labelling index, steriod hormone receptors, DNA ploidy. Int J Cancer 1991, 47, 213-220.
21. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976, 121, 545-552.
22. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.